Država: Malezija
Jezik: angleščina
Source: NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)
ERYTHROMYCIN; TRETINOIN
THE ZYFAS MEDICAL CO.,
ERYTHROMYCIN; TRETINOIN
10 gm
DaeHwa Pharmaceutical Co.Ltd
_ CONSUMER MEDICATION INFORMATION LEAFLET (RIMUP) _ E-SOL GEL Erythromycin 4%, Tretinoin 0.025% 1 WHAT IS IN THIS LEAFLET 1. What E-SOL GEL is used for 2. How E-SOL GEL works 3. Before you use E-SOL GEL 4. How to use E-SOL GEL 5. While you are using it 6. Side effects 7. Storage and disposal of E-SOL GEL 8. Product description 9. Manufacturer and Product Registration Holder 10. Date of revision WHAT E-SOL GEL IS USED FOR Treatment of acne. HOW E-SOL GEL WORKS E-sol is a gel contains Erythromycin and Tretinoin as active ingredients. Erythromycin is an antibiotic which kills the germs found in acne and reduces the inflammation of your skin. Tretinoin is an agent which modifies abnormal skin cell renewal. BEFORE YOU USE E-SOL GEL -_ When you must not apply it _ - If you are allergic to any components in E-SOL GEL - If you have a type of skin cancer known as epithelioma or have family history of it. - if your skin is sunburnt - if you are using any other medication on your skin which may lead to skin irritation e.g. an exfoliator - if you are suffering from acute eczema, rosacea (a skin disease which affects the face and is characterized by redness, pimples and peeling) or acute inflammatory conditions of the skin, especially around the mouth. - if you are pregnant - if you are planning a pregnancy _-Before you start to apply it _ - For external use only. Excessive use should be avoided. - Exposure to excessive sunlight, including sunlamps, should be avoided while using the preparation, or a suitably effective sunscreen should be employed. - Cosmetics may be used, but the areas to be treated should be cleansed thoroughly before the medication is applied. - Do not use E-sol Gel if you are pregnant or thinking of becoming pregnant. Your doctor can give you more information. _- Apply other medicines _ E-Sol gel should not be used concomitantly with other skin medications particularly those containing keratolytic agents, as this may exacerbate any skin irritation that is present. HOW TO USE E-SOL GEL _-How much to apply Preberite celoten dokument
E-SOL GEL NAME AND STRENGTH OF ACTIVE SUBSTANCE(S) Erythromycin ……………………. 4 % w/w Tretinoin…………………………..0.025%ww PRODUCT DESCRIPTION Homogeneous opaque gel PHARMACODYNAMICS / PHARMACOKINETICS ●Pharmacodynamics Erythromycin is a macrolide antibiotic with bacteriostatic action on all pathogens involved in the development of acne. When applied topically it also effects a reduction in the concentration of skin surface lipids and shows a direct anti-inflammatory effect. The retinoid tretinoin acts topically as keratolytic agent by markedly increasing cell turnover in the cornified epithelium including epithelium of the follicular ducts and comedones. In the first instance, skin irritation, erythema and increased vascularization occur followed by thickening and desquamation of the epithelium. The renewal time of the cornified epithelium is therefore shortened. ●Pharmacokinetics Percutaneous absorption or erythromycin is negligible following topical application of E-Sol Gel for several to large areas of skin .After topical application, up to 6% of the applied dose of tretinoin is recovered in the urine within 50-60 hours, indicating some absorption. The ratio of renal to biliary excretion is approximately 1:3, therefore the maximum likely total absorption is 24% INDICATION E-Sol Gel is indicated for topical application in the treatment of all forms of acne, both non- inflammatory forms with comedones and inflammatory forms with papules and pustules particularly those associated with a very oily skin. RECOMMENDED DOSAGE AND ADMINISTRATION The dosage is the same for all ages. The duration of use depends on the condition of the skin and should not exceed 12 weeks. E-Sol gel should be applied once a day, in the evening, to the skin where acne lesions appear, using enough to cover the entire affected area lightly. Application may cause a transient feeling of warmth or slight stinging. In cases where it has been necessary to temporarily discontinue therapy or reduce the frequency of appl Preberite celoten dokument